Literature DB >> 10344629

Inhibition by magnolol of formylmethionyl-leucyl-phenyl alanine-induced respiratory burst in rat neutrophils.

J P Wang1, M F Hsu, S L Raung, L C Chang, L T Tsao, P L Lin, C C Chen.   

Abstract

The influence of the plant product magnolol on neutrophil superoxide anion (O2-*) generation has been investigated in the rat. Intraperitoneal injection of magnolol (30mg kg(-1)) significantly inhibited the formylmethionyl-leucyl-phenylalanine (fMLP)-induced respiratory burst in rat whole blood ex-vivo. Magnolol also inhibited the 02-* generation with an IC50 (concentration resulting in 50% inhibition) of 15.4+/-1.6 microM and O2 consumption in rat neutrophils in-vitro. Magnolol weakly inhibited the O2-* generation in the xanthine-xanthine oxidase system, decreased cellular cyclic AMP level and had no effect on cyclic GMP levels. It weakly inhibited neutrophil cytosolic protein kinase C activity but did not alter porcine heart protein kinase A activity. Magnolol attenuated fMLP-induced protein tyrosine phosphorylation with an IC50 of 24.0+/-1.9 microM and the phosphorylation of mitogen-activated protein kinase p42/44 with an IC50 of 28.5+/-4.5 microM. However, magnolol alone activated neutrophil phospholipase D activity as determined by the formation of phosphatidic acid and phosphatidyl-ethanol in the presence of ethanol. In the presence of NADPH, the arachidonate-activated NADPH oxidase activity in a cell-free system was weakly suppressed by magnolol. These results suggest that the inhibition of respiratory burst in fMLP-activated neutrophils by magnolol is probably attributable mainly to the attenuation of protein tyrosine phosphorylation and p42/44 mitogen-activated protein kinase activation, and partly to the suppression of protein kinase C and NADPH oxidase activities.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10344629     DOI: 10.1211/0022357991772466

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  11 in total

1.  Magnolol protects osteoblastic MC3T3-E1 cells against antimycin A-induced cytotoxicity through activation of mitochondrial function.

Authors:  Eun Mi Choi
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

2.  Stimulation of the BK(Ca) channel in cultured smooth muscle cells of human trachea by magnolol.

Authors:  S-N Wu; C-C Chen; H-F Li; Y-K Lo; S-A Chen; H-T Chiang
Journal:  Thorax       Date:  2002-01       Impact factor: 9.139

3.  Magnolol Inhibits LPS-induced NF-κB/Rel Activation by Blocking p38 Kinase in Murine Macrophages.

Authors:  Mei Hong Li; Gugan Kothandan; Seung Joo Cho; Pham Thi Thu Huong; Yong Hai Nan; Kun Yeong Lee; Song Yub Shin; Sung Su Yea; Young Jin Jeon
Journal:  Korean J Physiol Pharmacol       Date:  2010-12-31       Impact factor: 2.016

Review 4.  Antagonism of human formyl peptide receptor 1 with natural compounds and their synthetic derivatives.

Authors:  Igor A Schepetkin; Andrei I Khlebnikov; Liliya N Kirpotina; Mark T Quinn
Journal:  Int Immunopharmacol       Date:  2015-09-15       Impact factor: 4.932

5.  The mechanism of honokiol-induced and magnolol-induced inhibition on muscle contraction and Ca2+ mobilization in rat uterus.

Authors:  Yu-Cheng Lu; Hwei-Hsien Chen; Chien-Hsin Ko; Yi-Ruu Lin; Ming-Huan Chan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-09-18       Impact factor: 3.000

Review 6.  NOX2 As a Target for Drug Development: Indications, Possible Complications, and Progress.

Authors:  Becky A Diebold; Susan M E Smith; Yang Li; J David Lambeth
Journal:  Antioxid Redox Signal       Date:  2014-03-24       Impact factor: 8.401

7.  Effect of magnolol on the function of osteoblastic MC3T3-E1 cells.

Authors:  Eun Jung Kwak; Young Soon Lee; Eun Mi Choi
Journal:  Mediators Inflamm       Date:  2012-02-09       Impact factor: 4.711

Review 8.  Current status of NADPH oxidase research in cardiovascular pharmacology.

Authors:  Bruno K Rodiño-Janeiro; Beatriz Paradela-Dobarro; María Isabel Castiñeiras-Landeira; Sergio Raposeiras-Roubín; José R González-Juanatey; Ezequiel Alvarez
Journal:  Vasc Health Risk Manag       Date:  2013-07-25

Review 9.  Honokiol and magnolol as multifunctional antioxidative molecules for dermatologic disorders.

Authors:  Jui-Lung Shen; Kee-Ming Man; Po-Hsun Huang; Wen-Chi Chen; Der-Cherng Chen; Ya-Wen Cheng; Po-Len Liu; Ming-Chih Chou; Yung-Hsiang Chen
Journal:  Molecules       Date:  2010-09-16       Impact factor: 4.411

Review 10.  Effects of Polyphenols on Oxidative Stress, Inflammation, and Interconnected Pathways during Spinal Cord Injury.

Authors:  Sajad Fakhri; Fatemeh Abbaszadeh; Seyed Zachariah Moradi; Hui Cao; Haroon Khan; Jianbo Xiao
Journal:  Oxid Med Cell Longev       Date:  2022-01-07       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.